Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 436

1.

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.

Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD.

Antimicrob Agents Chemother. 2002 Jun;46(6):1781-4.

2.

In vitro bactericidal activity of daptomycin against staphylococci.

Fuchs PC, Barry AL, Brown SD.

J Antimicrob Chemother. 2002 Mar;49(3):467-70.

PMID:
11864946
3.

Parameters for quality control of antimicrobial susceptibility tests of roxithromycin.

Barry AL, Brown SD.

Clin Microbiol Infect. 1999 Apr;5(4):233-234. No abstract available.

4.

In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime.

Fuchs PC, Barry AL, Brown SD.

J Antimicrob Chemother. 2002 Feb;49(2):399-401.

PMID:
11815588
7.

Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media.

Fuchs PC, Barry AL, Brown SD.

J Antimicrob Chemother. 2001 Oct;48(4):557-61.

PMID:
11581238
8.

Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.

Barry AL, Fuchs PC, Brown SD.

Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):494-7.

PMID:
11561807
9.

In vitro activity of the ketolide ABT-773.

Barry AL, Fuchs PC, Brown SD.

Antimicrob Agents Chemother. 2001 Oct;45(10):2922-4.

11.

Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests.

Barry AL, Fuchs PC, Brown SD.

J Antimicrob Chemother. 2001 Jul;48(1):121-5.

PMID:
11418522
12.
13.

In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.

Barry AL, Fuchs PC, Brown SD.

Antimicrob Agents Chemother. 2001 Jun;45(6):1923-7.

14.

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers.

Barry AL, Fuchs PC, Brown SD.

Antimicrob Agents Chemother. 2001 Jun;45(6):1919-22.

15.
16.
17.

Quality control parameters for cefditoren susceptibility tests.

Fuchs PC, Barry AL, Brown SD, Traczewski MM.

Clin Microbiol Infect. 2001 Feb;7(2):93-5. No abstract available.

18.

Quality control parameters for susceptibility tests of Haemophilus influenzae against three carbapenems.

Barry AL, Brown SD.

Clin Microbiol Infect. 2000 Sep;6(9):500-2. No abstract available.

19.

Revision of quality control limits for cefotaxime disk susceptibility tests.

Barry AL, Brown SD.

Clin Microbiol Infect. 2000 May;6(5):285-6. No abstract available.

22.

Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

Fuchs PC, Barry AL, Brown SD.

Diagn Microbiol Infect Dis. 2000 Sep;38(1):51-8.

PMID:
11025184
23.
24.

Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.

Fuchs PC, Barry AL, Brown SD.

Diagn Microbiol Infect Dis. 2000 Aug;37(4):265-9.

PMID:
10974578
25.

Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Barry AL, Pfaller MA, Brown SD, Espinel-Ingroff A, Ghannoum MA, Knapp C, Rennie RP, Rex JH, Rinaldi MG.

J Clin Microbiol. 2000 Sep;38(9):3457-9.

26.

Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.

Jorgensen JH, Barry AL, Traczewski MM, Sahm DF, McElmeel ML, Crawford SA.

J Clin Microbiol. 2000 Aug;38(8):2814-8.

27.

Lack of effect of antibiotic resistance on susceptibility of microorganisms to chlorhexidine gluconate or povidone iodine.

Barry AL, Fuchs PC, Brown SD.

Eur J Clin Microbiol Infect Dis. 1999 Dec;18(12):920-1. No abstract available.

PMID:
10691210
28.

In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents.

Fuchs PC, Barry AL, Brown SD.

Antimicrob Agents Chemother. 1999 Dec;43(12):2996-7.

29.
30.
31.
33.

Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae.

Barry AL, Brown SD, Fuchs PC.

J Antimicrob Chemother. 1999 Mar;43(3):428-9. No abstract available.

PMID:
10223606
35.
37.

PMX-622 (polymyxin B-dextran 70) does not alter in vitro activities of 11 antimicrobial agents.

Fuchs PC, Barry AL, Brown SD.

Antimicrob Agents Chemother. 1998 Oct;42(10):2765-7.

38.
39.
40.

In vitro antimicrobial activity of MSI-78, a magainin analog.

Fuchs PC, Barry AL, Brown SD.

Antimicrob Agents Chemother. 1998 May;42(5):1213-6.

42.

Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin.

Fuchs PC, Barry AL, Brown SD.

J Chemother. 1997 Dec;9(6):391-3.

PMID:
9491837
44.
45.

Susceptibility testing quality control studies with fosfomycin tromethamine.

Fuchs PC, Barry AL, Brown SD.

Eur J Clin Microbiol Infect Dis. 1997 Jul;16(7):538-40.

PMID:
9272392
46.

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.

Barry AL, Fuchs PC, Brown SD.

J Antimicrob Chemother. 1997 Jul;40(1):139-40. No abstract available.

PMID:
9249220
47.

Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests.

Barry AL, Fuchs PC, Brown SD.

J Antimicrob Chemother. 1997 May;39 Suppl A:87-92.

PMID:
9511070
48.

Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619.

Fuchs PC, Barry AL, Brown SD, Allen SD, Bauman M, Jorgensen JH, Tenover FC.

Diagn Microbiol Infect Dis. 1997 May;28(1):27-9.

PMID:
9218915
49.

Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin.

Fuchs PC, Barry AL, Brown SD.

J Antimicrob Chemother. 1997 May;39(5):671-2. No abstract available.

PMID:
9184374
50.

Is Escherichia coli ATCC 25922 useful for monitoring broth microdilution tests of fluoroquinolones?

Fuchs PC, Barry AL, Brown SD.

J Antimicrob Chemother. 1997 Apr;39(4):549-50. No abstract available.

PMID:
9145831

Supplemental Content

Loading ...
Support Center